|
KR100848121B1
(ko)
*
|
1998-07-01 |
2008-07-24 |
캘리포니아 인스티튜트 오브 테크놀로지 |
선형 사이클로덱스트린 공중합체
|
|
US7091192B1
(en)
*
|
1998-07-01 |
2006-08-15 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
US6509323B1
(en)
*
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
US7375096B1
(en)
*
|
1998-12-04 |
2008-05-20 |
California Institute Of Technology |
Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
|
|
WO2000033885A1
(en)
*
|
1998-12-04 |
2000-06-15 |
California Institute Of Technology |
Supramolecular complexes containing therapeutic agents
|
|
US6740643B2
(en)
*
|
1999-01-21 |
2004-05-25 |
Mirus Corporation |
Compositions and methods for drug delivery using amphiphile binding molecules
|
|
KR100371720B1
(ko)
*
|
2000-07-03 |
2003-02-06 |
광주과학기술원 |
사이클로덱스트린 또는 이의 유도체와 이작용성 또는다작용성 히드록시 화합물의 축중합물, 및 이의 제조방법
|
|
RU2288921C2
(ru)
*
|
2000-12-19 |
2006-12-10 |
Калифорниа Инститьют оф Текнолоджи |
Композиции, содержащие комплексы включения
|
|
TWI321054B
(en)
*
|
2000-12-19 |
2010-03-01 |
California Inst Of Techn |
Compositions containing inclusion complexes
|
|
EP1275404A1
(de)
*
|
2001-07-11 |
2003-01-15 |
SCA Hygiene Products AB |
Geruchtskontrolle für Hygieneprodukte
|
|
JP2005527639A
(ja)
|
2001-11-02 |
2005-09-15 |
インサート セラピューティクス インコーポレイテッド |
Rna干渉の治療的利用のための方法及び組成物
|
|
US20040063654A1
(en)
*
|
2001-11-02 |
2004-04-01 |
Davis Mark E. |
Methods and compositions for therapeutic use of RNA interference
|
|
US7141540B2
(en)
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
|
TW515107B
(en)
*
|
2001-12-25 |
2002-12-21 |
Solidlite Corp |
Power-saving light-emitting diode lamp
|
|
CA2476769A1
(en)
*
|
2002-02-22 |
2003-09-04 |
Insert Therapeutics, Inc. |
Carbohydrate-modified polymers, compositions and uses related thereto
|
|
AU2003219922B2
(en)
*
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
US20050260259A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
FR2842106B1
(fr)
*
|
2002-07-11 |
2006-07-14 |
Centre Nat Rech Scient |
Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques
|
|
KR20140070676A
(ko)
*
|
2002-09-06 |
2014-06-10 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
|
CA2818071C
(en)
*
|
2002-09-06 |
2015-08-18 |
Cerulean Pharma Inc. |
Modified cyclodextrin ring compounds having exactly two hydroxyl moieties substituted with an amino acid for therapeutics delivery
|
|
BR0315198A
(pt)
*
|
2002-10-09 |
2005-08-30 |
Insert Therapeutics Inc |
Materiais e composições à base de ciclodextrina e usos relacionados aos mesmos
|
|
AU2003304204B2
(en)
*
|
2002-10-29 |
2009-12-24 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
SG129240A1
(en)
*
|
2003-01-23 |
2007-02-26 |
Agency Science Tech & Res |
Biodegradable copolymer and nucleic acid delivery system
|
|
CA2518475C
(en)
|
2003-03-07 |
2014-12-23 |
Alnylam Pharmaceuticals, Inc. |
Irna agents comprising asymmetrical modifications
|
|
US20070179100A1
(en)
*
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
|
CA2522349A1
(en)
|
2003-04-17 |
2004-11-04 |
Alnylam Pharmaceuticals, Inc. |
Protected monomers
|
|
EP2669377A3
(de)
|
2003-04-17 |
2015-10-14 |
Alnylam Pharmaceuticals Inc. |
Modifizierte iRNA-Wirkstoffe
|
|
US8796436B2
(en)
|
2003-04-17 |
2014-08-05 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
|
US7851615B2
(en)
*
|
2003-04-17 |
2010-12-14 |
Alnylam Pharmaceuticals, Inc. |
Lipophilic conjugated iRNA agents
|
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
|
US8017762B2
(en)
*
|
2003-04-17 |
2011-09-13 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
|
WO2005004794A2
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
|
WO2005084180A2
(en)
|
2003-12-19 |
2005-09-15 |
University Of Cincinnati |
Polyamides and polyamide complexes for delivery of oligonucleotide decoys
|
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
|
WO2005065435A2
(en)
|
2003-12-31 |
2005-07-21 |
Cydex, Inc. Et Al. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
|
ATE508190T1
(de)
|
2004-03-05 |
2011-05-15 |
Benitec Inc |
Mehrfachpromotor-expressionskassetten zurgleichzeitigen zuführung von rnai-agentien
|
|
ATE446581T1
(de)
*
|
2004-03-12 |
2009-11-15 |
Trinity College Dublin |
Magnetoresistives medium
|
|
EP1797252A1
(de)
*
|
2004-09-18 |
2007-06-20 |
Mirae Green Construction Co., Ltd. |
Gerät zur verhinderung von erdeintritt in einen auffangkanal
|
|
AU2006204120A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Benitec, Inc. |
RNAi agents for maintenance of stem cells
|
|
US7803611B2
(en)
|
2005-02-03 |
2010-09-28 |
Benitec, Inc. |
RNAi expression constructs
|
|
US8008468B2
(en)
*
|
2005-02-16 |
2011-08-30 |
Benitec, Inc. |
RNAi expression constructs with liver-specific enhancer/promoter
|
|
PL1866414T3
(pl)
|
2005-03-31 |
2012-10-31 |
Calando Pharmaceuticals Inc |
Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
|
|
CA2606002A1
(en)
*
|
2005-04-28 |
2006-11-02 |
Benitec Limited |
Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
|
|
EP1948674A4
(de)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
Modifizierte sirna-moleküle und anwendungen davon
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
US20080275139A1
(en)
*
|
2005-12-19 |
2008-11-06 |
Capsutech Ltd. |
Cyclodextrin-Containing Polymers and Uses Thereof
|
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
|
CA2642577A1
(en)
*
|
2006-02-15 |
2007-08-23 |
Tika Lakemedel Ab |
Methods of manufacturing corticosteroid solutions
|
|
US8501478B2
(en)
|
2006-06-15 |
2013-08-06 |
University Of Cincinnati |
Trehalose click polymers for delivery of biologically active molecules
|
|
US20080176958A1
(en)
*
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US12370352B2
(en)
|
2007-06-28 |
2025-07-29 |
Cydex Pharmaceuticals, Inc. |
Nasal and ophthalmic delivery of aqueous corticosteroid solutions
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
TW200918099A
(en)
*
|
2007-09-14 |
2009-05-01 |
Nitto Denko Corp |
Drug carriers
|
|
EP2194068B1
(de)
*
|
2007-09-28 |
2013-04-17 |
Nanodex INC. |
Mit folsäure modifizierte cyclodextrinverbindung, verfahren zu ihrer herstellung, wirkstofffreisetzungsmittel für ein zielgerichtetes wirkstofffreisetzungssystem, pharmazeutische zusammensetzung und bildgebungsmittel
|
|
US8040246B2
(en)
*
|
2007-12-04 |
2011-10-18 |
Avaya Inc. |
Systems and methods for facilitating a first response mission at an incident scene
|
|
US9006191B2
(en)
|
2007-12-27 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering RNA
|
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
JP2011516065A
(ja)
|
2008-04-04 |
2011-05-26 |
カランド ファーマシューティカルズ, インコーポレイテッド |
Epas1阻害剤の組成物および使用
|
|
WO2009129319A2
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
|
AU2009273878A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Alnylam Pharmaceuticals, Inc. |
Enhancement of siRNA silencing activity using universal bases or mismatches in the sense strand
|
|
US8309530B2
(en)
*
|
2009-02-04 |
2012-11-13 |
Washington State University |
Compositions and methods for modulating ghrelin-mediated conditions
|
|
EP2401225B1
(de)
|
2009-02-26 |
2014-10-22 |
The Regents of The University of California |
Supramolekulares verfahren zur herstellung von grössenkontrollierbaren nanopartikeln
|
|
BR112012012210B8
(pt)
|
2009-11-23 |
2021-05-25 |
Cerulean Pharma Inc |
conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
|
|
WO2011090940A1
(en)
|
2010-01-19 |
2011-07-28 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CA2927832C
(en)
|
2010-05-18 |
2021-03-23 |
Cerulean Pharma Inc. |
Cyclodextrin-containing polymer-therapeutic agent conjugates and their use
|
|
JP2013530187A
(ja)
|
2010-06-17 |
2013-07-25 |
ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
炎症性疾患を治療するための組成物及び方法。
|
|
SG186899A1
(en)
|
2010-07-08 |
2013-02-28 |
Bonac Corp |
Single-strand nucleic acid molecule for controlling gene expression
|
|
ES2533129T3
(es)
|
2010-08-03 |
2015-04-07 |
Bonac Corporation |
Molécula de ARN monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
|
|
CN103328500B
(zh)
|
2010-08-04 |
2018-01-26 |
西兹尔生物技术有限公司 |
用于癌症的诊断和治疗的方法和化合物
|
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
WO2012061409A1
(en)
|
2010-11-01 |
2012-05-10 |
Marshall Edwards, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
|
US20120302505A1
(en)
*
|
2011-04-21 |
2012-11-29 |
Fetzer Oliver S |
Cyclodextrin-based polymers for therapeutic delivery
|
|
EP2780456A1
(de)
|
2011-11-17 |
2014-09-24 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Therapeutische rna schalter-zusammensetzungen und anwendungsverfahren dafür
|
|
CA2859046C
(en)
|
2011-12-14 |
2019-10-22 |
The Johns Hopkins University |
Nanoparticles with enhanced mucosal penetration or decreased inflammation
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
WO2013103146A1
(ja)
|
2012-01-07 |
2013-07-11 |
株式会社ボナック |
アミノ酸骨格を有する一本鎖核酸分子
|
|
US9415020B2
(en)
|
2012-01-19 |
2016-08-16 |
The Johns Hopkins University |
Nanoparticle formulations with enhanced mucosal penetration
|
|
HK1205156A1
(en)
*
|
2012-01-31 |
2015-12-11 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
US9598503B2
(en)
|
2012-04-18 |
2017-03-21 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
|
PL2852391T3
(pl)
|
2012-05-21 |
2022-04-11 |
Insmed Incorporated |
Układy do leczenia infekcji płuc
|
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
|
CA2891487A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
US10568975B2
(en)
|
2013-02-05 |
2020-02-25 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
|
WO2015127389A1
(en)
|
2014-02-23 |
2015-08-27 |
The Johns Hopkins University |
Hypotonic enema formulations and methods of use
|
|
JP6763780B2
(ja)
|
2014-05-12 |
2020-09-30 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
合成脳浸透遺伝子ベクターの操作
|
|
WO2015175545A1
(en)
|
2014-05-12 |
2015-11-19 |
The Johns Hopkins University |
Highly stable biodegradable gene vector platforms for overcoming biological barriers
|
|
MX384843B
(es)
|
2014-05-15 |
2025-03-14 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
|
|
US10415037B2
(en)
|
2014-10-02 |
2019-09-17 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis B virus gene expression
|
|
JP6846351B2
(ja)
|
2015-01-27 |
2021-03-24 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
|
|
PT3253208T
(pt)
|
2015-02-02 |
2021-06-17 |
The Spanish National Cancer Res Centre |
Terapêuticas de combinação para utilização no tratamento do cancro da mama
|
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
|
CN108350455A
(zh)
|
2015-07-29 |
2018-07-31 |
阿布特斯生物制药公司 |
用于使b型肝炎病毒基因表达沉默的组合物和方法
|
|
US12514872B2
(en)
|
2015-11-04 |
2026-01-06 |
Duke University |
Polycationic polymers for use in treating and detecting cancer
|
|
EP3405501B1
(de)
*
|
2016-01-21 |
2023-11-15 |
Aten Porus Lifesciences |
Polymere auf cyclodextrinbasis, verfahren, zusammensetzungen und anwendungen davon
|
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーYale Universit |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
|
WO2018039131A1
(en)
|
2016-08-22 |
2018-03-01 |
Protiva Biotherapeutics, Inc. |
Anti-pd-1 antibodies, or fragments thereof, for treating hepatitis b
|
|
US20200093932A1
(en)
*
|
2016-12-01 |
2020-03-26 |
Bluelink Pharmaceuticals, Inc. |
Treatment of cancer
|
|
AU2017379901B2
(en)
|
2016-12-21 |
2024-02-15 |
Arbutus Biopharma Corporation |
Methods for ameliorating infusion reactions
|
|
US12447464B2
(en)
|
2016-12-22 |
2025-10-21 |
Duke University |
Polycationic microfibers and methods of using the same
|
|
EP3590972A4
(de)
|
2017-03-02 |
2020-03-18 |
Osaka University |
Host-gruppenhaltiges polymerisierbares monomer, polymermaterial, verfahren zur herstellung davon und clathratverbindung und verfahren zur herstellung davon
|
|
WO2018169960A1
(en)
|
2017-03-17 |
2018-09-20 |
The Johns Hopkins University |
Nanoparticle formulations for enhanced drug delivery to the bladder
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
WO2019074110A1
(ja)
|
2017-10-13 |
2019-04-18 |
株式会社ボナック |
一本鎖核酸分子およびその製造方法
|
|
US10765638B2
(en)
|
2017-11-03 |
2020-09-08 |
Yale University |
Particle formulation with polycation complex
|
|
EP3773505B1
(de)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
|
|
EP3787602A4
(de)
|
2018-05-02 |
2022-03-23 |
Insmed Incorporated |
Verfahren zur herstellung von liposomalen arzneimittelformulierungen
|
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
|
WO2020210805A1
(en)
|
2019-04-11 |
2020-10-15 |
The Johns Hopkins University |
Nanoparticles for drug delivery to brain
|
|
CN110016194A
(zh)
*
|
2019-04-16 |
2019-07-16 |
无锡纯宇环保制品有限公司 |
一种有利于水体净化的可降解塑料袋
|
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
WO2021081043A1
(en)
|
2019-10-22 |
2021-04-29 |
The Johns Hopkins University |
Mucus penetrating particle compositions and methods of use thereof enhancing immune response
|
|
EP4192509A1
(de)
|
2020-08-05 |
2023-06-14 |
Ellipses Pharma Ltd |
Behandlung von krebs mit einem cyclodextrinhaltigen polymer-topoisomerase-inhibitor-konjugat und einem parp-inhibitor
|
|
US20230414700A1
(en)
|
2020-10-15 |
2023-12-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tg2 inhibitors for improving mucociliary clearance in respiratory diseases
|
|
CN115160454A
(zh)
*
|
2021-04-01 |
2022-10-11 |
四川大学 |
一种基于聚-β-环糊精与金刚烷主客体作用的超分子多醛化合物及其制备方法
|
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
US20250241999A1
(en)
|
2021-10-15 |
2025-07-31 |
Georgia State University Research Foundation, Inc. |
Delivery of therapeutic recombinant uricase using nanoparticles
|
|
KR20250009961A
(ko)
*
|
2022-05-17 |
2025-01-20 |
린텍 가부시키가이샤 |
점착성 조성물, 점착제, 점착 시트, 표시체 및 반복 굴곡 디바이스
|
|
EP4701639A1
(de)
|
2023-05-31 |
2026-03-04 |
University of Tartu |
Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davon
|
|
WO2025184504A1
(en)
|
2024-02-28 |
2025-09-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Thermo-sensitive anti-fungal hydrogel compositions and methods of use
|
|
WO2025264861A1
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Compositions of bi-functional alpha helical peptides and methods thereof for treating tdp-43 proteinopathies
|
|
WO2026006542A2
(en)
|
2024-06-26 |
2026-01-02 |
Yale University |
Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
|
|
WO2026085322A1
(en)
|
2024-10-18 |
2026-04-23 |
Aardvark Therapeutics Inc. |
Isoflavonoid formulations and methods of use
|
|
WO2026107236A1
(en)
|
2024-11-13 |
2026-05-21 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for vaccination against mycobacterium tuberculosis
|